Which cancers is niraparib tosylate monohydrate licensed to treat?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

It is licensed as maintenance treatment for specified high-grade ovarian, fallopian tube and primary peritoneal cancers after a response to platinum-based chemotherapy.

Sources for this answer

Zejula 100mg Tabletsemc · SmPC Current selected SmPC · Version 8

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

privacy terms

mobile app · scan to download

Medicines niraparib tosylate monohydrateQuestion & answer

niraparib tosylate monohydrate · Medicine question

Which cancers is niraparib tosylate monohydrate licensed to treat?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

It is licensed as maintenance treatment for specified high-grade ovarian, fallopian tube and primary peritoneal cancers after a response to platinum-based chemotherapy.

Sources for this answer

Zejula 100mg Tabletsemc · SmPC Current selected SmPC · Version 8

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

niraparib tosylate monohydrate

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the niraparib tosylate monohydrate guide

Answer

Sources for this answer

Answer

Sources for this answer

More questions about niraparib tosylate monohydrate